Luke Nordquist, MD, FACP, CEO
drluke@xcancer.comTony Romero, MS, CCRC, Director of Research
tromero@gucancer.comDescription:
This study aims to evaluate the diagnostic efficacy and prognostic value of 18F-FAPI PET/CT in lung cancer.
Sponsor:
First Affiliated Hospital of Zhejiang University
Phase:
N/A
Contacts:
Donghe Chen, MDchendonghe@zju.edu.cn
0571-87236432
Government Study Link:
NCT07370805 - Click here to see study onClinicalTrials.gov
Help us improve your experience